TIGR LOSS ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages UP Fintech Holding Limited Investors to Inquire About Securities Class Action Investigation - TIGR PR Newswire NEW YORK, June 10, 2023 NEW YORK , June 10, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of UP Fintech Holding Limited (NASDAQ: TIGR) resulting from allegations that UP Fintech may have issued materially...
BOWL INVESTOR NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Bowlero Corp. Investors to Inquire About Securities Class Action Investigation - BOWL PR Newswire NEW YORK, June 10, 2023 NEW YORK , June 10, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Bowlero Corp. (NYSE: BOWL) resulting from allegations that Bowlero may have issued materially misleading business information...
ALLBIRDS SHAREHOLDER ACTION REMINDER : Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Allbirds To Contact Him Directly To Discuss Their Options PR Newswire NEW YORK, June 10, 2023 NEW YORK , June 10, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Allbirds, Inc ("Allbirds" or the "Company") (NASDAQ: BIRD) and reminds investors of the June 12, 2023...
NUTANIX SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Nutanix To Contact Him Directly To Discuss Their Options PR Newswire NEW YORK, June 10, 2023 NEW YORK , June 10, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Nutanix, Inc. ("Nutanix" or the "Company") (NASDAQ: NTNX) and reminds investors of the June 13, 2023 deadline to...
SENTINELONE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In SentinelOne To Contact Him Directly To Discuss Their Options PR Newswire NEW YORK, June 10, 2023 NEW YORK , June 10, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against SentinelOne, Inc. ("SentinelOne" or the "Company") (NYSE: S) and reminds investors of the August 7, 2023...
ATLAS LITHIUM SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Atlas Lithium To Contact Him Directly To Discuss Their Options PR Newswire NEW YORK, June 10, 2023 NEW YORK , June 10, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Atlas Lithium Corporation ("Atlas Lithium" or the "Company") (NASDAQ: ATLX) and reminds investors of...
CUTERA SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Cutera To Contact Him Directly To Discuss Their Options PR Newswire NEW YORK, June 10, 2023 NEW YORK , June 10, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Cutera, Inc. ("Cutera" or the "Company") (NASDAQ: CUTR) and reminds investors of the July 24, 2023 deadline to...
BEYOND MEAT SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Beyond Meat To Contact Him Directly To Discuss Their Options PR Newswire NEW YORK, June 10, 2023 NEW YORK , June 10, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Beyond Meat, Inc. ("Beyond Meat" or the "Company") (NASDAQ: BYND) and reminds investors of the July 10,...
STEM SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Stem To Contact Him Directly To Discuss Their Options PR Newswire NEW YORK, June 10, 2023 NEW YORK , June 10, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Stem, Inc. ("Stem" or the "Company") f/k/a Star Peak Energy Transition Corp. ("STPK") (NYSE: STEM; STEM.WS; STPK;...
FUNKO SHAREHOLDER ACTION REMINDER : Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Funko To Contact Him Directly To Discuss Their Options PR Newswire NEW YORK, June 10, 2023 NEW YORK , June 10, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Funko, Inc. ("Funko" or the "Company") (NASDAQ: FNKO) and reminds investors of the August 1, 2023 deadline to seek...
FIRST REPUBLIC SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In First Republic To Contact Him Directly To Discuss Their Options PR Newswire NEW YORK, June 10, 2023 NEW YORK , June 10, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against First Republic Bank ("First Republic" or the "Company") (NYSE: FRC) and reminds investors of the...
7 of 10 r/r NHL patients achieved complete response (70% CR rate) following treatment with NKX019 monotherapy at 1 billion and 1.5 billion CAR NK cells per dose in the Phase 1 dose escalation study Data demonstrate potential for redosing of allogeneic CD19 CAR NK to deepen response or restore response post-relapse Majority of patients achieved CR after a single cycle of NKX019 Early safety data support potential of allogeneic CD19 CAR NK to be administered on outpatient basis No neurotoxicity /...
Data on CD19/BCMA dual-targeting FasTCAR-T GC012F showed 100% overall response rate (ORR) and 66.7% 6-month complete response (CR) rate among treated patients, all with diffuse large B-cell lymphoma (DLBCL) subtype Data on GC012F for treatment of relapsed/refractory multiple myeloma ( RRMM) and donor-derived CAR-T GC007g for treatment of relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL) have been presented as posters on June 9 at EHA2023 SAN DIEGO, Calif., and SUZHOU and...
TOP RANKED ROSEN LAW FIRM Encourages TriplePoint Venture Growth BDC Corp. Investors to Inquire About Securities Class Action Investigation - TPVG PR Newswire NEW YORK, June 10, 2023 NEW YORK , June 10, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of TriplePoint Venture Growth BDC Corp. (NYSE: TPVG) resulting from allegations that TriplePoint may have issued materially misleading...
FUNKO, INC. CLASS ACTION ALERT: WOLF HALDENSTEIN ADLER FREEMAN & HERZ LLP REMINDS INVESTORS THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN FILED IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF WASHINGTON AGAINST FUNKO, INC. PR Newswire NEW YORK, June 10, 2023 LE AD PLAINTIFF DEADLINE IS AUGUST 1, 2023 NEW YORK , June 10, 2023 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein") announces that a federal securities class action lawsuit has been filed in...
CUTERA, INC. CLASS ACTION ALERT: WOLF HALDENSTEIN ADLER FREEMAN & HERZ LLP REMINDS INVESTORS THAT A SECURITIES CLASS ACTION LAWSUIT HAS BEEN FILED IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA AGAINST CUTERA, INC. PR Newswire NEW YORK, June 10, 2023 LE AD PLAINTIFF DEADLINE IS JULY 24, 2023 NEW YORK , June 10, 2023 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein") announces that a federal securities class action lawsuit has been filed in...
WOLF HALDENSTEIN ADLER FREEMAN & HERZ LLP IS INVESTIGATING POTENTIAL SECURITIES CLAIMS AGAINST INTEGRA LIFESCIENCES HOLDINGS CORP. ON BEHALF OF INTEGRA STOCKHOLDERS PR Newswire NEW YORK, June 10, 2023 NEW YORK , June 10, 2023 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein") is investigating potential claims against Integra LifeSciences Holdings Corp. ("Integra" or the "Company") (NASDAQ: IART) on behalf of Integra stockholders. A ll investors who purchased shares...
WOLF HALDENSTEIN ADLER FREEMAN & HERZ LLP IS INVESTIGATING POTENTIAL SECURITIES CLAIMS AGAINST MICROVAST HOLDINGS, INC. PR Newswire NEW YORK, June 10, 2023 NEW YORK , June 10, 2023 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein") announces that it is investigating claims on behalf of investors of Microvast Holdings, Inc. ("Microvast" or "the Company") (NASDAQ:MVST) for violations of the securities laws.. A ll investors who purchased shares and incurred losses are...
